IRIS
DI TARANTO, MARIA DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.775
EU - Europa 2.256
NA - Nord America 2.087
SA - Sud America 382
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.585
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.977
SG - Singapore 1.550
RU - Federazione Russa 1.104
CN - Cina 664
IT - Italia 503
BR - Brasile 311
HK - Hong Kong 218
VN - Vietnam 190
DE - Germania 143
NL - Olanda 123
CA - Canada 70
FI - Finlandia 65
GB - Regno Unito 62
FR - Francia 51
IE - Irlanda 45
CI - Costa d'Avorio 40
IN - India 38
SE - Svezia 33
AR - Argentina 32
MX - Messico 29
UA - Ucraina 29
BD - Bangladesh 22
PL - Polonia 21
KR - Corea 20
ZA - Sudafrica 19
AT - Austria 17
IQ - Iraq 13
ES - Italia 11
EC - Ecuador 10
RO - Romania 10
CO - Colombia 9
ID - Indonesia 7
KE - Kenya 7
AE - Emirati Arabi Uniti 6
JP - Giappone 6
PY - Paraguay 6
CH - Svizzera 5
MA - Marocco 5
PE - Perù 5
PK - Pakistan 5
TR - Turchia 5
AL - Albania 4
BE - Belgio 4
CZ - Repubblica Ceca 4
LT - Lituania 4
NP - Nepal 4
VE - Venezuela 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
IL - Israele 3
JO - Giordania 3
LV - Lettonia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AM - Armenia 2
BY - Bielorussia 2
CL - Cile 2
HN - Honduras 2
HR - Croazia 2
NI - Nicaragua 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
IR - Iran 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
ME - Montenegro 1
ML - Mali 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RE - Reunion 1
SD - Sudan 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
YT - Mayotte 1
ZM - Zambia 1
Totale 7.585
Salva come PNG Salva come JPEG
Città #
Singapore 767
Moscow 239
Chandler 223
Beijing 217
Hong Kong 211
Ashburn 202
Hefei 134
Santa Clara 108
Naples 103
Amsterdam 89
Los Angeles 84
Napoli 67
Millbury 66
Ho Chi Minh City 60
San Jose 48
Boardman 46
Boston 46
New York 44
Princeton 41
Nanjing 37
Hanoi 36
Ottawa 33
São Paulo 33
Des Moines 32
Munich 31
Buffalo 29
Lawrence 27
Redondo Beach 27
Dong Ket 26
Dallas 25
Nuremberg 24
Rome 24
The Dalles 22
Milan 20
Seattle 20
Seoul 20
Helsinki 19
Denver 17
Warsaw 17
Wilmington 17
Brooklyn 15
Toronto 15
Dublin 14
Frankfurt am Main 14
Jacksonville 14
Mexico City 14
Washington 14
Nanchang 13
Woodbridge 13
Rio de Janeiro 12
Stockholm 12
Augusta 11
Chennai 11
Poplar 11
Brasília 10
Johannesburg 10
London 10
Montreal 10
Orem 10
Redwood City 10
San Francisco 10
Timisoara 10
Chicago 9
Falkenstein 9
Houston 9
Norwalk 9
Shanghai 9
Shenyang 9
Baghdad 8
Curitiba 8
Düsseldorf 8
Ercolano 8
Haiphong 8
Portsmouth 8
Turku 8
Cercola 7
Hebei 7
Nairobi 7
Tianjin 7
Belo Horizonte 6
Da Nang 6
Manchester 6
Ninh Bình 6
Palermo 6
Phoenix 6
Thái Bình 6
Xi'an 6
Bologna 5
Caserta 5
Council Bluffs 5
Dhaka 5
Guayaquil 5
Hangzhou 5
Kronberg 5
Lappeenranta 5
Marsala 5
Rimini 5
Roubaix 5
Secaucus 5
Tokyo 5
Totale 3.845
Salva come PNG Salva come JPEG
Nome #
Galectin-3 and Lp(a) plasma concentrations and advanced carotid atherosclerotic plaques: correlation with plaque presence and features 154
A case of cerebrotendinous xanthomatosis in a woman with a normal cholesterolemia. 128
Identification and functional characterization of a new mutation leading to defective uptake of LDL-LDLR complex. 122
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 122
Decreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis 119
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 116
Expression of inflammation-related genes in human atherosclerotic plaques. 113
A case of cerebrotendinous xantomatosis in a woman with a normal colesterolemia 112
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 112
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 110
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 110
Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy 109
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 109
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 109
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 108
Identification of deletions in LDLR gene by Multiplex Ligation-Dependent Probe Amplification Analysis. 107
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 107
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 106
Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL/HDL ratio 106
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 105
An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations. 104
Identification of Single Nucleotide Polymorphisms associated to Familial Combined Hyperlipidemia. 102
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 101
Familial hypercholesterolemia: a flow chart for the molecular diagnosis. 101
Investigation of Single Nucleotide Polymorphisms Associated to Familial Combined Hyperlipidemia with Random Forests. 101
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 100
Expression of inflammation-related genes in human atherosclerotic plaque. 100
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients 99
Familial hypercholesterolemia: A complex genetic disease with variable phenotypes 99
Carotid Endarterectomy versus Carotid Artery Stenting with Double-Layer Micromesh Carotid Stent: contemporary results of a single-center retrospective study 99
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 98
Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis 95
Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population. 95
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 95
Familial Combined Hyperlipidemia: identification of misdiagnosed patients by detection of LDLR mutations. 94
A first comparative study on two cell colture techniques – stimulated T cells and continous lymphoblastoid cell lines – in the detection of LDL receptor residual activity versus molecular genetic analysys 94
Relazione tra polimorfismi del gene paraoxonasi ed ischemia miocardica indotta da stress in pazienti con sospetta malattia coronarica 94
Age-related changes of cholestanol and lathosterol plasma concentrations: An explorative study 94
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 93
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 93
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 93
Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports 92
The role of immunosuppressive therapy in aneurysmal degeneration of hemodialysis fistulas in renal transplant patients: Aneurysmatic arteriovenous fistula in transplant patients 92
Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases 91
Identificazione e caratterizzazione funzionale di mutazioni nel gene LDLR in pazienti del sud Italia affetti da Ipercolesterolemia familiare. 91
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 91
EXPRESSION OF ADIPONECTIN RECEPTORS IN HUMAN CAROTID ATHEROSCLEROTIC PLAQUES Abstracts from the 12th National Congress of the Italian Society of Cardiovascular Prevention (SIPREC), Naples, 6–8 March 2014 90
Correlation between low adenosine A2A receptor expression and hypercholesterolemia: A new component of the cardiovascular risk? 90
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 88
Simplified Criteria for Identification of Familial Hypercholesterolemia in Children: Application in Real Life 88
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 88
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 88
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 87
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 86
ECHOCARDIOGRAFIC ANDECO-DOPPLER ABNORMALITIESIN RELATION TO LDL CHOLESTEROLIN FAMILIAL HYPERCHOLESTEROLEMIA 86
The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family 86
Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: Integration and evolution of genetic diagnosis 86
Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena) 86
Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. 85
Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia 85
Targeting Nanostrategies for Imaging of Atherosclerosis 85
Advances in Computational Methods for Genetic Diseases 82
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 81
C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging 80
Identification of single nucleotide polymorphisms associated to familial combined hyperlipidemia 78
IDENTIFICATION OF LDLR MUTATIONSIN PATIENTS WITH FAMILIAL COMBINEDHYPERLIPIDEMIA 78
Identification of deletions in LDRR gene by multiplex ligation-dependent probe amplification analysis 77
MANAGEMENT OF SEVEREHYPERCHOLESTEROLEMIA IN A FAMILYBEARING C.974G>A LDL RECEPTORMUTATION 74
IDENTIFICATION AND FUNCTIONALCHARACTERIZATION OF A NEW MUTATIONLEADING TO DEFECTIVE UPTAKEOF LDL-LDLR COMPLEX 73
Homozygous Familial Hypercholesterolemia in Campania 72
Endovascular Treatment Versus Medical Therapy for Hypertensive Patients with Renal Artery Stenosis: An Updated Systematic Review 71
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 71
Molecular diagnosis of Familial Hypercholesterolemia: the utility of a country specific protocol. 70
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 68
Valutazione di parametri di ossidazione in placche aterosclerotiche e plasma di pazienti endoarteriectomizzati. 66
The role of galectin-3 and LP(A) in atherosclerosis: A combined analysis of serum levels and plaque characteristics 66
The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9 66
Metalloproteinases between History, Health, Disease, and the Complex Dimension of Social Determinants of Health 65
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 55
Clinical and Pathological Correlations in Chronic Venous Disease 51
Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia 50
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization 46
Harnessing the potential of metalloproteinases in extracellular vesicles: a window of opportunity for aneurysm management 45
Multiparametric platform for profiling lipid trafficking in human leukocytes 43
Galectin-3 in cardiovascular diseases 41
Studio del miRNome e caratterizzazione funzionale del LDLR per l’identificazione di nuove cause molecolari dell’ipercolesterolemia familiare [miRNome study and functional characterization of LDLR for the identification of new molecular causes of Familial Hypercholesterolemia] 39
Statistical and Computational Methods for Genetic Diseases: An Overview 35
Totale 7.732
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021110 0 0 0 0 0 0 6 13 14 10 31 36
2021/2022423 21 5 2 14 14 22 7 17 32 15 116 158
2022/2023573 72 23 24 26 91 70 3 57 87 85 29 6
2023/2024503 30 69 40 35 28 49 12 70 4 20 76 70
2024/20252.583 115 117 22 90 61 157 267 177 162 265 942 208
2025/20263.029 599 338 471 444 902 223 52 0 0 0 0 0
Totale 7.732